Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats

References

• Ahr H. J., King L. J., Nastainczyk W., Ullrich V. The mechanism of reductive dehalogenation of halothane by cytochrome P-450. Biochemical Pharmacology 1982; 31: 383–390
   PubMed Web of Science ®Google Scholar
• Brown B. R., Sipes I. G. Biotransformation and hepatotoxicity of halothane. Biochemical Pharmacology 1977; 26: 2091–2094
   PubMed Web of Science ®Google Scholar
• Chen P. S., Toribara T. Y., Warner H. Microdetermination of phosphorus. Analytical Chemistry 1956; 28: 1756–1758
   Web of Science ®Google Scholar
• Cohen E. N. Metabolism of halothane-214C in the mouse. Anesthesiology 1969; 31: 560–565
   PubMedGoogle Scholar
• Cousins M. J., Sharp J. H., Gourlay G. K., Adams J. G., Haynes W. D., Whitehead R. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anaesthetics and Intensive Care 1979; 7: 9–24
   PubMed Web of Science ®Google Scholar
• De Groot H., Noll T. Halothane hepatotoxicity: Relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology 1983; 3: 601–606
   PubMed Web of Science ®Google Scholar
• DiRenzo A. B., Gandolfi A. J., Sipes I. G., Brendel K. Effect of O2 tension on the bioactivation and metabolism of aliphatic halides by primary rat-hepatocyte cultures. Xenobiotica 1984; 14: 521–525
   PubMed Web of Science ®Google Scholar
• Franklin M. R., Estabrook R. W. On the inhibitor action of mersalyl on microsomal drug oxidation: A rigid organization of the electron transport chain. Archives of Biochemistry and Biophysics 1971; 143: 318–329
   PubMed Web of Science ®Google Scholar
• Fujii K., Morio M., Kikuchi H. A possible role of cytochrome P-450 in anaerobic dehalogenation of halothane. Biochemical and Biophysical Research Communications 1981a; 101: 1158–1163
   PubMed Web of Science ®Google Scholar
• Fujii K., Miki N., Sugiyama T., Morio M., Yamano T., Miyake Y. Anaerobic dehalogenation of halothane by reconstituted liver microsomal cytochrome P-450 enzyme system. Biochemical and Biophysical Research Communications 1981b; 102: 507–512
   PubMedGoogle Scholar
• Gandolfi A. J., White R. D., Sipes I. G., Pohl L. R. Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane. Journal of Pharmacology and Experimental Therapeutics 1980; 214: 721–725
   PubMed Web of Science ®Google Scholar
• Harper M. H., Collins P., Johnson B., Eger E. I., Biava C. Hepatic injury following halothane, enflurane, and isoflurane anesthesia in rats. Anesthesiology 1982; 56: 14–17
   PubMedGoogle Scholar
• Karashima D., Hirokata Y., Shigematsu A., Furukawa T. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450. Journal of Pharmacology and Experimental Therapeutics 1977; 203: 409–416
   PubMed Web of Science ®Google Scholar
• Legler D., Van Dyke R. A. Microsomal lipids as targets for halothane metabolites. Research Communications in Chemical Pathology and Pharmacology 1982; 37: 395–402
   PubMedGoogle Scholar
• Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J. Protein measurements with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Maiorino R. M., Sipes I. G., Gandolfi A. J., Brown B. R., Lind R. C. Factors affecting the formation of chlorotrifluoroethane and chlorodifluoroethylene from halothane. Anesthesiology 1981; 54: 383–389
   PubMedGoogle Scholar
• McLain G. E., Sipes I. G., Brown B. R. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia. Anesthesiology 1979; 51: 321–326
   PubMed Web of Science ®Google Scholar
• Nastainczyk W., Ullrich V., Sies H. Effect of oxygen concentration on the reaction of halothane with cytochrome P-450 in liver microsomes and isolated perfused rat liver. Biochemical Pharmacology 1978; 27: 387–392
   PubMed Web of Science ®Google Scholar
• Neuberger J., Kenna J. G. Halothane hepatitis: a model of immune mediated drug hepatotoxicity. Clinical Sciences 1987; 72: 263–270
   Google Scholar
• Rao G. S. A study of the mechanism of halothane-induced liver necrosis. Role of covalent binding of halothane metabolites to liver proteins in the rat. Journal of Medical Chemistry 1977; 20: 262–265
   PubMedGoogle Scholar
• Reynolds E. S., Moslen M. T. Liver injury following halothane anesthesia in phenobarbital-pretreated rats. Biochemical Pharmacology 1974; 23: 189–195
   PubMed Web of Science ®Google Scholar
• Ross W. T., Daggy B. P., Cardell R. R. Hepatic necrosis caused by halothane and hypoxia in phenobarbital-treated rats. Anesthesiology 1979; 51: 327–333
   PubMed Web of Science ®Google Scholar
• Satoh H., Gillette J. R., Takemura T., Ferrans V. J., Jelenich S. E., Kenna J. G., Neuberger J., Pohl L. R. Investigation of the immunological basis of halothane-induced hepatotoxicity. Advances in Experimental Medical Biology 1986; 197: 657–673
   PubMedGoogle Scholar
• Siegers C.-P., Fruhling A., Younes M. Halothane hepatotoxicity in hyperthyroid rats as compared to the phenobarbital-hypoxia model. Toxicology and Applied Pharmacology 1983; 69: 257–264
   PubMed Web of Science ®Google Scholar
• Sipes I. G., Brown B. R. An animal model of hepatotoxicity associated with halothane anesthesia. Anesthesiology 1976; 45: 622–628
   PubMed Web of Science ®Google Scholar
• Smith A. C., Berman M. L., James R. C., Harbison R. D. Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity. Biochemical Pharmacology 1983; 32: 3531–3539
   PubMed Web of Science ®Google Scholar
• Smith A. C., James R. C., Berman M. L., Harbison R. D. Paradoxical effects of perturbation of intracellular levels of glutathione on halothane-induced hepatotoxicity in hyperthyroid rats. Fundamental and Applied Toxicology 1984; 4: 221–230
   PubMedGoogle Scholar
• Smith A. C., Roberts S. M., Berman L. M., Harbison R. D., James R. C. Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat. Toxicology 1988, in press
   Google Scholar
• Stenger R. J., Johnson E. A. Effects of phenobarbital pretreatment on the response of rat liver to halothane administration. Proceedings of the Society for Experimental Biology and Medicine 1972; 140: 1319–1324
   PubMedGoogle Scholar
• Uehleke H., Hellmer K. H., Tabarelli-Poplawski S. Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro. Naunyn Schmiedeberg's Archives of Pharmacology 1973; 279: 39–52
   PubMed Web of Science ®Google Scholar
• Van Dyke R. A., Chenowith M. B. The metabolism of volatile anesthetics. II. In vitro metabolism of methoxyflurane and halothane in rat liver slices and cell fractions. Biochemical Pharmacology 1965; 14: 603–609
   PubMedGoogle Scholar
• Van Dyke R. A., Gandolfi A. J. Studies on irreversible binding of radioactivity from [14C]halothane to rat hepatic microsomal lipids and protein. Drug Metabolism and Disposition 1974; 2: 469–476
   PubMedGoogle Scholar
• Van Dyke R. A., Gandolfi A. J. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents. Drug Metabolism and Disposition 1976; 4: 40–44
   PubMed Web of Science ®Google Scholar
• Van Dyke R. A., Wood C. L. Binding of radioactivity from 14C-labeled halothane in isolated perfused rat livers. Anesthesiology 1973; 38: 328–332
   PubMed Web of Science ®Google Scholar
• Van Dyke R. A., Wood C. L. In vitro studies on irreversible binding of halothane metabolite to microsomes. Drug Metabolism and Disposition 1975; 3: 51–57
   PubMed Web of Science ®Google Scholar
• Widger L. A., Gandolfi A. J., Van Dyke R. A. Hypoxia and halothane metabolism in vivo: Release of inorganic fluoride and halothane metabolite binding to cellular constituents. Anesthesiology 1976; 44: 197–201
   PubMed Web of Science ®Google Scholar
• Wood C. L., Gandolfi A. J., Van Dyke R. A. Lipid binding of a halothane metabolite. Relationship to lipid peroxidation in vitro. Drug Metabolism and Disposition 1976; 4: 305–313
   PubMedGoogle Scholar
• Wood M., Berman M. L., Harbison R. D., Hoyle P., Phythyon J. M., Wood A. J. J. Halothane-induced hepatic necrosis in triiodothyronine-pretreated rats. Anesthesiology 1980; 52: 470–476
   PubMed Web of Science ®Google Scholar